Chronic Obstructive Pulmonary Disease |OMICS International | Journal Of Vaccines And Vaccination

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Pulmonary Disease

Chronic Obstructive Pulmonary Disease is responsible for an increasing burden of disease throughout the world, such that by 2030, the World Health Organization estimates that COPD will become the third leading cause of death worldwide. In high income countries, tobacco smoke is the biggest risk factor for COPD, while in low-income countries, indoor air pollution, especially exposure to smoke from cooking stoves, is a major risk factor for COPD. Acute exacerbations of COPD frequently result in hospitalization, and are responsible for a substantial burden on patients and the health care system. These exacerbations are often triggered by bacterial or viral infections, and COPD patients are known to be at particular risk of complications arising from seasonal influenza viruses. Finding effective ways to prevent respiratory infections in COPD is an important priority. Evaluation of Immune Responses to Influenza Vaccination in Chronic Obstructive Pulmonary Disease: Julie G Burel, Karthik Nath, Antonia L Pritchard, Olivia J White, Janet M Davies, Michelle Towers, David Looke and John W.Upham
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on January, 2021